End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.069 SEK | -4.43% |
|
-25.49% | +4.39% |
26/02 | QuiaPEG Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/02 | QuiaPEG, Net Zero Infrastructure Nears Conclusion of Formal License Agreement | MT |
Sales 2022 | 55.74L 5L 4.43Cr | Sales 2023 | 43.74L 4L 3.48Cr | Capitalization | 27.29L 3L 2.17Cr |
---|---|---|---|---|---|
Net income 2022 | -2Cr -19.04L -16Cr | Net income 2023 | -1.6Cr -15.24L -13Cr | EV / Sales 2022 | 7.85 x |
Net Debt 2022 | 1.3Cr 12.34L 10Cr | Net Debt 2023 | 2.05Cr 19.53L 16Cr | EV / Sales 2023 | 5.31 x |
P/E ratio 2022 |
-1.15
x | P/E ratio 2023 |
-1.97
x | Employees | 3 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 66.36% |
1 day | -4.43% | ||
1 week | -25.49% | ||
Current month | -8.00% | ||
1 month | +2.99% | ||
3 months | +38.00% | ||
6 months | -9.09% | ||
Current year | +4.39% |
![Extreme 0.0501](/images/extremecours_fleche.png)
![Extreme 0.0501](/images/extremecours_fleche.png)
![Extreme 0.0463](/images/extremecours_fleche.png)
![Extreme 0.0261](/images/extremecours_fleche.png)
![Extreme 0.0261](/images/extremecours_fleche.png)
![Extreme 0.0261](/images/extremecours_fleche.png)
![Extreme 0.0261](/images/extremecours_fleche.png)
Date | Price | Change | Volume |
---|---|---|---|
20/24/20 | 0.069 | -4.43% | 7,188,867 |
19/24/19 | 0.0722 | +15.34% | 33,774,220 |
18/24/18 | 0.0626 | -14.13% | 1,598,363 |
17/24/17 | 0.0729 | -21.27% | 4,839,903 |
14/24/14 | 0.0926 | +5.23% | 1,635,876 |
End-of-day quote Nasdaq Stockholm, June 20, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+4.39% | 5L | |
+51.63% | 80TCr | |
+41.51% | 63TCr | |
-5.10% | 36TCr | |
+19.90% | 33TCr | |
+9.95% | 30TCr | |
+17.66% | 24TCr | |
+3.39% | 23TCr | |
+10.75% | 21TCr | |
+6.99% | 17TCr |
- Stock Market
- Equities
- QUIA Stock